|
You can find more information about
The ARCHITECT HIV Ag/Ab Combo assay can help diagnose HIV infection before antibodies appear in the blood…
FDA Requirements for Colleague Infusion Pump Recall
How Baxter Healthcare is carrying out the recall of its Colleague volumetric infusion pumps…
Air/Gas Embolisms with Pressurized Spray Devices
Adverse events may be associated with not using the devices according to their labeling and instructions…
Expanded Recall of Hospira Liposyn and Propofol
Affected injectable products may contain particulate matter...
Recall of Certain LIFEPAK Defibrillators
Possible failures in AC or DC power that could delay or prevent these devices from delivering therapy…
Mylotarg Withdrawn from
Recent clinical trial failed to show clinical benefit for this cancer drug, and also raised safety concerns…
Revised warnings emphasize that certain patients have a higher risk of suicide if they are treated with tramadol…
Velcade and Hepatic Impairment
Patients with moderate to severe hepatic impairment who are beginning therapy with the drug should be started at reduced doses and closely monitored for toxicity…
Shortage of EPINEPHrine Syringes Can Cause Errors
ASHP and ISMP recommendations to help avoid errors during the shortage…
Avoiding Patient Injuries with Dermatome Instruments
Reports stated that the injuries resulted from improper maintenance…
Phase-Out of Epinephrine CFC Metered-Dose Inhalers
Epinephrine inhalers that use CFCs as a propellant, such as Primatene Mist, will not be sold in the
For more
You are receiving this message because you subscribed to the
Manage your FDA Subscriptions:
- Update your preferences or unsubscribe
- Questions about this service? support@xxxxxxxxxxxxxxx
- Other inquiries? webmail@xxxxxxxxxx
U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420
